X |
Filing Date |
Trade Date |
Ticker |
Company Name | Insider Name | Title |
Trade Type |
Price |
Qty |
Owned |
ΔOwn |
Value |
1d |
1w |
1m |
6m |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2022-01-18 | IRMD | Iradimed Corp | Susi Roger E. | Pres, CEO, COB, 10% | S - Sale | $41.21 | -10,000 | 5,497,950 | 0% | -$412,056 | ||||||
2022-01-14 | SWAV | Shockwave Medical, Inc. | Zacharias Isaac | Chief Commercial Officer | S - Sale | $175.37 | -4,000 | 72,079 | -5% | -$701,480 | ||||||
2022-01-14 | ATRC | Atricure, Inc. | Austin Tonya | CHRO | S - Sale | $66.11 | -2,719 | 22,830 | -11% | -$179,753 | ||||||
2022-01-12 | TELA | Tela Bio, Inc. | Ew Healthcare Partners Fund 2, L.P. | See footnote 2 | P - Purchase | $12.50 | +5,000 | 1,917,637 | 0% | +$62,500 | ||||||
| D | 2022-01-11 | PEN | Penumbra Inc | Elsesser Adam | CEO, Pres | S - Sale+OE | $253.34 | -14,500 | 957,582 | -1% | -$3,673,489 | |||||
| D | 2022-01-11 | SILK | Silk Road Medical Inc | Rogers Erica J. | Pres, CEO | S - Sale+OE | $41.88 | -10,000 | 216,022 | -4% | -$418,787 | |||||
2022-01-11 | IRMD | Iradimed Corp | Susi Roger E. | Pres, CEO, COB, 10% | S - Sale | $44.54 | -10,000 | 5,507,950 | 0% | -$445,379 | ||||||
| DM | 2022-01-10 | TMCI | Treace Medical Concepts, Inc. | Scanlan Sean F. | SVP, Marketing | S - Sale+OE | $20.15 | -47,700 | 0 | -100% | -$961,378 | |||||
| M | 2022-01-10 | TELA | Tela Bio, Inc. | Ew Healthcare Partners Fund 2, L.P. | See footnote 2 | P - Purchase | $12.40 | +6,409 | 1,912,637 | 0% | +$79,456 | |||||
2022-01-12 | ANGO | Angiodynamics Inc | Trowbridge Stephen A | EVP, CFO | P - Purchase | $22.64 | +1,000 | 76,081 | +1% | +$22,640 | ||||||
2022-01-11 | ANGO | Angiodynamics Inc | Clemmer James C | Pres, CEO | P - Purchase | $22.84 | +10,000 | 390,764 | +3% | +$228,400 | ||||||
| D | 2022-01-10 | RMD | Resmed Inc | Sandercock Brett | CFO | S - Sale+OE | $235.00 | -2,500 | 106,354 | -2% | -$587,500 | |||||
| M | 2022-01-06 | ICAD | Icad Inc | Sassine Andy | Dir | S - Sale | $6.14 | -20,000 | 1,218,382 | -2% | -$122,700 | |||||
2022-01-10 | SPNE | Seaspine Holdings Corp | Gaeta Renee | Dir | S - Sale | $12.35 | -2,000 | 24,113 | -8% | -$24,700 | ||||||
2022-01-06 | TTOO | T2 Biosystems, Inc. | Ahuja Aparna | Chief Medical Officer | S - Sale | $0.48 | -61,988 | 107,611 | -37% | -$29,754 | ||||||
| D | 2022-01-05 | ABMD | Abiomed Inc | Trapp Todd A | VP, CFO | S - Sale+OE | $359.43 | -1,000 | 14,063 | -7% | -$359,430 | |||||
| D | 2022-01-05 | PODD | Insulet Corp | Petrovic Shacey | Pres, CEO | S - Sale+OE | $264.97 | -15,000 | 84,909 | -15% | -$3,974,550 | |||||
2022-01-04 | NARI | Inari Medical, Inc. | Hoffman William | Pres, CEO | S - Sale | $94.05 | -30,000 | 449,821 | -6% | -$2,821,455 | ||||||
2022-01-04 | SRDX | Surmodics Inc | Stich Joseph J. | SVP, HR, GM, IVD | S - Sale | $50.00 | -2,500 | 45,839 | -5% | -$125,000 | ||||||
| DM | 2022-01-04 | INSP | Inspire Medical Systems, Inc. | Ban Randy | Chief Commercial Officer | S - Sale+OE | $241.60 | -10,307 | 599 | -95% | -$2,490,174 | |||||
| DM | 2022-01-03 | TMCI | Treace Medical Concepts, Inc. | Scanlan Sean F. | SVP, Marketing | S - Sale+OE | $20.02 | -2,300 | 0 | -100% | -$46,039 | |||||
2022-01-03 | PEN | Penumbra Inc | Sarna Surbhi | Dir | S - Sale | $285.34 | -94 | 1,325 | -7% | -$26,822 | ||||||
| D | 2022-01-03 | PEN | Penumbra Inc | Roberts Johanna | EVP, Gen. Counsel, Secretary | S - Sale+OE | $281.57 | -3,250 | 57,624 | -5% | -$915,093 | |||||
2022-01-03 | PEN | Penumbra Inc | Grewal Harpreet | Dir | S - Sale | $285.34 | -634 | 10,730 | -6% | -$180,906 | ||||||
2022-01-04 | PEN | Penumbra Inc | Wilder Thomas | Dir | S - Sale | $283.99 | -80 | 4,007 | -2% | -$22,719 | ||||||
| D | 2022-01-03 | CERS | Cerus Corp | Moore Carol | SVP Reg., Quality | S - Sale+OE | $7.00 | -19,059 | 181,276 | -10% | -$133,417 | |||||
| D | 2022-01-03 | TNDM | Tandem Diabetes Care Inc | Berger David B | EVP, Bus Ops, Compliance | S - Sale+OE | $149.16 | -1,000 | 4,693 | -18% | -$149,163 | |||||
| D | 2022-01-03 | NVCR | Novocure Ltd | Burke William Patrick | CHRO | S - Sale+OE | $76.00 | -3,951 | 50,870 | -7% | -$300,263 | |||||
2022-01-04 | BSX | Boston Scientific Corp | Mirviss Jeffrey B. | EVP, Pres, Periph Intervent | S - Sale | $43.54 | -6,840 | 133,153 | -5% | -$297,806 | ||||||
2022-01-04 | BSX | Boston Scientific Corp | Pierce David A | EVP Pres MedSurg | S - Sale | $43.54 | -6,161 | 0 | -100% | -$268,230 | ||||||
| D | 2022-01-05 | INO | Inovio Pharmaceuticals, Inc. | Zoth Lota S. | Dir | S - Sale+OE | $5.01 | -961 | 25,016 | -4% | -$4,815 | |||||
2022-01-05 | ICAD | Icad Inc | Stevens Stacey M | Pres | P - Purchase | $6.17 | +17,006 | 154,627 | +12% | +$104,927 | ||||||
2022-01-04 | DYNT | Dynatronics Corp | Ward R Scott | Dir | P - Purchase | $0.00 | +5,000 | 87,078 | +6% | +$0 | ||||||
2022-01-04 | DYNT | Dynatronics Corp | Provco Ventures 1 LP | 10% | P - Purchase | $0.00 | +37,552 | 1,087,082 | +4% | +$0 | ||||||
2022-01-04 | DYNT | Dynatronics Corp | Larkin Brian | Dir | P - Purchase | $0.00 | +3,734 | 202,106 | +2% | +$0 | ||||||
2022-01-04 | DYNT | Dynatronics Corp | Klosterman Scott | Dir | P - Purchase | $0.00 | +5,000 | 104,829 | +5% | +$0 | ||||||
2022-01-04 | DYNT | Dynatronics Corp | Holtz David B | Dir | P - Purchase | $0.00 | +5,000 | 104,829 | +5% | +$0 | ||||||
2022-01-04 | DYNT | Dynatronics Corp | Essig Stuart | 10% | P - Purchase | $0.00 | +80,146 | 1,993,450 | +4% | +$0 | ||||||
2022-01-04 | DYNT | Dynatronics Corp | Enright Erin S. | Dir | P - Purchase | $0.00 | +80,146 | 1,993,450 | +4% | +$0 | ||||||
2022-01-04 | DYNT | Dynatronics Corp | Baker Brian D. | Dir | P - Purchase | $0.00 | +8,734 | 111,903 | +8% | +$0 | ||||||
2021-12-31 | TELA | Tela Bio, Inc. | Ew Healthcare Partners Fund 2, L.P. | See footnote 2 | P - Purchase | $12.46 | +5,928 | 1,906,228 | 0% | +$73,863 | ||||||
| DM | 2021-12-30 | INFU | Infusystem Holdings, Inc | Sheehan Jeannine | Chief Administrative Officer | S - Sale+OE | $17.01 | -7,943 | 17,952 | -31% | -$135,100 | |||||
2022-01-04 | IRMD | Iradimed Corp | Susi Roger E. | Pres, CEO, COB, 10% | S - Sale | $48.56 | -10,000 | 5,517,950 | 0% | -$485,629 | ||||||
2022-01-03 | BSX | Boston Scientific Corp | Olson Scott | SVP, Pres, CRM, Diagnostics | S - Sale | $42.59 | -700 | 12,062 | -5% | -$29,813 | ||||||
2021-12-31 | PODD | Insulet Corp | McMillan Wayde D. | EVP, CFO | S - Sale | $268.98 | -1,855 | 20,078 | -8% | -$498,956 | ||||||
2021-12-30 | ATAO | Altair International Corp. | Fourth Street Fund, LP | Owner of 43% of Issuer | S - Sale | $0.03 | -3,300,000 | 244,293,050 | -1% | -$89,100 | ||||||
2021-12-30 | ATAO | Altair International Corp. | Lovallo Leonard | Pres | S - Sale | $0.03 | -150,000 | 29,280,000 | -1% | -$4,110 | ||||||
| D | 2021-12-27 | NXGL | Nexgel, Inc. | Zeldis Jerome B | Dir | P - Purchase | $5.49 | +9,091 | 82,728 | +12% | +$49,910 | |||||
| D | 2021-12-27 | NXGL | Nexgel, Inc. | Toledano Miranda Jayne | Dir | P - Purchase | $5.49 | +1,819 | 1,819 | New | +$9,986 | |||||
| D | 2021-12-27 | NXGL | Nexgel, Inc. | Stein Nachum | Dir | P - Purchase | $5.49 | +28,000 | 476,358 | +6% | +$153,720 | |||||
| D | 2021-12-27 | NXGL | Nexgel, Inc. | Stefansky David | Dir | P - Purchase | $5.49 | +9,091 | 187,663 | +5% | +$49,910 | |||||
| D | 2021-12-27 | NXGL | Nexgel, Inc. | Glassman Steven Mark | Dir | P - Purchase | $5.49 | +5,000 | 109,592 | +5% | +$27,450 | |||||
2021-12-29 | XAIR | Beyond Air, Inc. | Lisi Steven A. | CEO, COB | S - Sale | $9.53 | -21,376 | 1,150,111 | -2% | -$203,756 | ||||||
2021-12-30 | DCTH | Delcath Systems, Inc. | Salamon Steven A J | Dir | P - Purchase | $7.56 | +2,000 | 421,500 | 0% | +$15,120 | ||||||
2021-12-30 | DCTH | Delcath Systems, Inc. | Rosalind Advisors, Inc. | Dir | P - Purchase | $7.56 | +2,000 | 423,500 | 0% | +$15,120 | ||||||
2021-12-30 | GBS | Gbs Inc. | Parmakellis Tom | Dir | P - Purchase | $1.55 | +4,500 | 9,300 | +94% | +$6,975 | ||||||
| M | 2021-12-28 | TMCI | Treace Medical Concepts, Inc. | Treace John T. | CEO, 10% | S - Sale | $17.00 | -22,835 | 10,746,709 | 0% | -$388,118 | |||||
2021-12-28 | TMCI | Treace Medical Concepts, Inc. | Treace James T | Dir | S - Sale | $16.88 | -1,563 | 2,467,626 | 0% | -$26,387 | ||||||
2021-12-29 | INFU | Infusystem Holdings, Inc | Ruiz Thomas Mark | Chief Commercial Officer | S - Sale | $17.00 | -76 | 16,980 | 0% | -$1,292 | ||||||
2021-12-29 | SWAV | Shockwave Medical, Inc. | Watkins Frank T | Dir | S - Sale | $176.25 | -20,000 | 35,802 | -36% | -$3,525,035 | ||||||
| DM | 2021-12-28 | ICUI | Icu Medical Inc/de | Jain Vivek | COB, CEO | S - Sale+OE | $240.00 | -12,000 | 72,779 | -14% | -$2,880,013 | |||||
| D | 2021-12-28 | NSPR | Inspiremd, Inc. | Roubin Gary S | Dir | P - Purchase | $3.08 | +16,393 | 128,694 | +15% | +$50,436 | |||||
| D | 2021-12-27 | LMAT | Lemaitre Vascular Inc | Pellegrino Joseph P Jr | CFO | S - Sale+OE | $52.00 | -807 | 8,848 | -8% | -$41,964 | |||||
| D | 2021-12-27 | TNDM | Tandem Diabetes Care Inc | Gasser Elizabeth Anne | EVP, Chief Strategy Officer | S - Sale+OE | $151.36 | -1,084 | 431 | -72% | -$164,075 | |||||
| D | 2021-12-27 | TFX | Teleflex Inc | Kelly Liam | COB, Pres, CEO | S - Sale+OE | $330.00 | -8,987 | 25,775 | -26% | -$2,965,710 | |||||
2021-12-28 | BSX | Boston Scientific Corp | Meredith Ian T | EVP Global Chief Med Officer | S - Sale | $43.21 | -7,018 | 26,243 | -21% | -$303,248 | ||||||
| D | 2021-12-27 | TNDM | Tandem Diabetes Care Inc | Leal James | SVP, Operations | S - Sale+OE | $151.45 | -1,906 | 4,008 | -32% | -$288,666 | |||||
| DM | 2021-12-23 | INSP | Inspire Medical Systems, Inc. | Ban Randy | Chief Commercial Officer | S - Sale+OE | $240.00 | -9,760 | 581 | -94% | -$2,342,400 | |||||
2021-12-27 | IRMD | Iradimed Corp | Susi Roger E. | Pres, CEO, COB, 10% | S - Sale | $47.11 | -10,000 | 5,551,050 | 0% | -$471,073 | ||||||
| A | 2021-11-29 | IONM | Assure Holdings Corp. | Parsons Preston T | FOUNDER, 10% | P - Purchase | $6.19 | +8,100 | 4,102,848 | 0% | +$50,139 | |||||
| M | 2021-12-22 | TMCI | Treace Medical Concepts, Inc. | Treace John T. | CEO, 10% | S - Sale | $16.72 | -81,670 | 10,769,544 | -1% | -$1,365,270 | |||||
| M | 2021-12-22 | TMCI | Treace Medical Concepts, Inc. | Treace James T | Dir | S - Sale | $16.64 | -42,437 | 2,469,189 | -2% | -$706,242 | |||||
2021-12-22 | XAIR | Beyond Air, Inc. | Carey Robert | Dir | P - Purchase | $9.50 | +10,000 | 518,418 | +2% | +$95,000 | ||||||
2021-12-21 | BEAT | Heartbeam, Inc. | Brounstein Richard D | CFO | P - Purchase | $3.37 | +5,000 | 102,075 | +5% | +$16,846 | ||||||
2021-12-23 | DXCM | Dexcom Inc | Pacelli Steven Robert | Managing Dir., Dexcom Ventures | S - Sale | $573.91 | -250 | 34,870 | -1% | -$143,478 | ||||||
| M | 2021-12-20 | TMCI | Treace Medical Concepts, Inc. | Treace John T. | CEO, 10% | S - Sale | $15.98 | -60,495 | 10,851,214 | -1% | -$966,440 | |||||
| M | 2021-12-20 | TMCI | Treace Medical Concepts, Inc. | Treace James T | Dir | S - Sale | $15.91 | -31,000 | 2,511,626 | -1% | -$493,345 | |||||
2021-12-20 | TELA | Tela Bio, Inc. | Ew Healthcare Partners Fund 2, L.P. | See footnote 2 | P - Purchase | $12.22 | +4,300 | 1,900,300 | 0% | +$52,546 | ||||||
2021-12-21 | IRMD | Iradimed Corp | Susi Roger E. | Pres, CEO, COB, 10% | S - Sale | $44.38 | -10,000 | 5,561,050 | 0% | -$443,800 | ||||||
2021-12-20 | ATRI | Atrion Corp | Battat Emile A | Dir, COB | S - Sale | $713.00 | -3 | 149,802 | 0% | -$2,139 | ||||||
2021-12-17 | GBS | Gbs Inc. | Life Science Biosensor Diagnostics Pty Ltd | 10% | S - Sale | $1.49 | -200,000 | 2,757,832 | -7% | -$298,000 | ||||||
| D | 2021-12-20 | SWAV | Shockwave Medical, Inc. | Puckett Dan | CFO | S - Sale+OE | $168.73 | -2,700 | 44,588 | -6% | -$455,559 | |||||
| D | 2021-12-20 | BSX | Boston Scientific Corp | Pierce David A | EVP Pres MedSurg | S - Sale+OE | $39.90 | -49,988 | 0 | -100% | -$1,994,621 | |||||
2021-12-16 | GBS | Gbs Inc. | Parmakellis Tom | Dir | P - Purchase | $1.69 | +2,800 | 4,800 | +140% | +$4,732 | ||||||
2021-12-16 | VERO | Venus Concept Inc. | Portaro Ross | Pres Global Sales | P - Purchase | $1.35 | +20,000 | 50,000 | +67% | +$27,000 | ||||||
2021-12-16 | ATEC | Alphatec Holdings, Inc. | Koning John Todd | CFO | P - Purchase | $11.17 | +5,000 | 196,682 | +3% | +$55,850 | ||||||
2021-12-15 | VERO | Venus Concept Inc. | Ew Healthcare Partners, L.P. | 10% | P - Purchase | $1.25 | +3,920,000 | 32,043,822 | +14% | +$4,900,000 | ||||||
2021-12-15 | VERO | Venus Concept Inc. | Barry Richard Scott | Dir, 10% | P - Purchase | $1.25 | +3,920,000 | 16,337,856 | +32% | +$4,900,000 | ||||||
2021-12-16 | LUNG | Pulmonx Corp | French Glendon E. III | Pres, CEO | S - Sale | $31.05 | -25,000 | 1,113,949 | -2% | -$776,220 | ||||||
2021-12-15 | NARI | Inari Medical, Inc. | Hykes Andrew | COO | S - Sale | $0.00 | -22,222 | 143,255 | -13% | -$0 | ||||||
2021-12-15 | TMCI | Treace Medical Concepts, Inc. | Treace James T | Dir | S - Sale | $16.06 | -75,000 | 3,084,204 | -2% | -$1,204,643 | ||||||
2021-12-15 | NARI | Inari Medical, Inc. | Hill, Mitch C. | CFO | S - Sale | $79.04 | -20,000 | 69,315 | -22% | -$1,580,744 | ||||||
| M | 2021-12-15 | TELA | Tela Bio, Inc. | Ew Healthcare Partners Fund 2, L.P. | See footnote 2 | P - Purchase | $12.44 | +10,050 | 1,896,000 | +1% | +$125,023 | |||||
| D | 2021-12-15 | TNDM | Tandem Diabetes Care Inc | Berger David B | EVP, Bus Ops, Compliance | S - Sale+OE | $144.25 | -12,000 | 4,693 | -72% | -$1,731,000 | |||||
2021-12-15 | VERO | Venus Concept Inc. | Healthquest Partners Ii, L.P. | 10% | P - Purchase | $1.25 | +1,600,000 | 6,795,621 | +31% | +$2,000,000 | ||||||
2021-12-15 | DXCM | Dexcom Inc | Sayer Kevin R | COB, CEO, Pres | S - Sale | $535.97 | -3,000 | 81,705 | -4% | -$1,607,899 | ||||||
2021-12-15 | VERO | Venus Concept Inc. | Sullivan Keith J | Dir | P - Purchase | $1.25 | +80,000 | 124,133 | +181% | +$100,000 | ||||||
2021-12-15 | VERO | Venus Concept Inc. | Kong Garheng | Dir, 10% | P - Purchase | $1.25 | +1,600,000 | 6,795,621 | +31% | +$2,000,000 | ||||||
| M | 2021-12-15 | SRTS | Sensus Healthcare, Inc. | Cohen Stephen Brad | EVP | S - Sale | $7.04 | -47,345 | 830,585 | -5% | -$333,225 | |||||
| M | 2021-12-15 | SRTS | Sensus Healthcare, Inc. | Sardano Joseph C | CEO | S - Sale | $7.00 | -24,227 | 1,463,649 | -2% | -$169,639 |
| A | Amended filing |
| D | Derivative transaction in filing (usually option exercise) |
| E | Error detected in filing |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |